HEALTHCARE, PRE IPO, PRIVATE PLACEMENT
Bart Vossen
Vice President,
Zhittya Genesis Medicine, Inc.
Follow
About Bart
Bart Vossen is vice president of Business Development of Regenerative Medicine of Southeast Asia., a biotech company with exclusive rights to Zhittya Genesis Medicines drugs that are being developed for heart disease, strokes, Parkinson's disease, Alzheimer's, and more.